DeutschNewstral
Article
The New York Times on 2023-05-10 10:14
U.S. loses key patent case on rights to HIV prevention drugs
Related news
- TPrioritize HIV/AIDS preventiontemple-news.com
Stakeholders task firm on patent right for HIV, hepatitis drugspunchng.com
Studies show success in HIV drugs for preventionsowetanlive.co.za- Long-acting drugs may revolutionize HIV prevention and treatmentThe New York Times
Facebook pulls deceptive ads on HIV prevention drugsArkansas Online
Out-of-pocket costs put HIV prevention drug out of reach for many at riskbradenton.com
Planned Parenthood of Greater Texas now offers HIV-prevention drugs, hormone therapyDallas News
HIV-prevention drugs to be available without a prescription in CaliforniaCNN
PrEP Made HIV Prevention Easier—and It’s Getting Even SimplerWired.com- Expert panel recommends new options for HIV preventionThe New York Times
What’s Up With HIV Prevention and Black Women?sacobserver.com
UC needs volunteers to test HIV prevention drugWCPO- Trump Administration Sues Gilead, Maker of H.I.V.-Prevention DrugsThe New York Times
- California Makes H.I.V.-Prevention Drugs Available Without a PrescriptionThe New York Times
- 200,000 Uninsured Americans to Get Free H.I.V.-Prevention DrugsThe New York Times
Transforming HIV prevention in EuropePolitico.eu
HIV: Newly Discovered Component Could Lead to More Effective Drugshuffingtonpost.com
Girl's HIV infection seems under control without AIDS drugswfsb.com
Girl’s HIV infection seems under control without AIDS drugsseattletimes.com